Table 2 Factors associated with higher mortality at day 30 in patients with CMV infection (n = 56)
From: Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy
Type of analysis | Univariate OR (95% CI) | Multivariate OR (95% CI) |
|---|---|---|
Age in years, older than 39. | 0.611 (1.52–245) p = 0.485 | |
ART*, yes | 4.1 (0.97–17.31) p = 0.044 | |
ICU admission, yes | 32.4 (3.65–287.06) p = 0.0001 | |
Mechanical Ventilation, yes | 84 (8.27–853.12) p = 0.0001 | 84 (8–853) p = 0.0001 |
HIV viral load, less than 284,000 copies/ml | 2.77 (0.638–12.1) p = 0.163 | |
CD4, less than 30 cells/mm3 | 0.56 (0.13–2.52), p = 0.411 | |
CMV*** BAL VL, less than 5300 copies/ml | 1.5 (0.85–2.64), p = 0.121 | |
CMV**** blood VL less than 3700 copies/ml | 3.8 (0.67–13.11) P 0.114 | |
Co morbidities, yes | 1.25 (0.3–5) p = 0.755 |